Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickening

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Cázares Domínguez, Vicenta ^a   Cruz Córdova, Ariadnna ^a   Ochoa, Sara A ^a   Escalona, Gerardo ^a   Arellano Galindo, José ^a   Rodríguez Leviz, Alejandra ^a   Hernández Castro, Rigoberto ^b   López Villegas, Edgar O ^c   Xicohtencatl Cortes, Juan ^a  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADOLESCENT; AGR GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CELL WALL THICKENING; CELLULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HOSPITAL INFECTION; HUMAN; INFANT; MALE; MEC GENE; MECIVA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR PHYLOGENY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; TRANSMISSION ELECTRON MICROSCOPY; VANCOMYCIN TOLERANT METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; ADAPTATION; CELL WALL; CHILD; CROSS INFECTION; CYTOLOGY; DRUG EFFECTS; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYLOGENY;

IVA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ADAPTATION, PHYSIOLOGICAL; CELL WALL; CHILD; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; GENOTYPE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PHYLOGENY; POLYMORPHISM, GENETIC; VANCOMYCIN;

EID: 84925882586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118791     Document Type: Article

References (50)

1. Aiken AM, Mutuku IM, Sabat AJ, Akkerboom V, Mwangi J, Scott JAG, et al. Carriage of Staphylococcus aureus in Thika Level 5 Hospital, Kenya: a cross-sectional study. Antimicrob Resist Infect Control. 2014; 3: 22. doi: 10.1186/2047-2994-3-22 PMID: 25057351
2. Appelbaum PC. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2006; 12 Suppl 1: 16-23. PMID: 16445720
3. Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis. 2006; 6: 156. PMID: 17067393
4. David MZ, Daum RS. Community-Associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010; 23: 616-687. doi: 10.1128/CMR.00081-09 PMID: 20610826
5. Rose WE, Fallon M, Moran JJM, Vanderloo JP. Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression. Antimicrob Agents Chemother. 2012; 56: 4422-4427. doi: 10.1128/AAC.00676-12 PMID: 22687502
6. May J, Shannon K, King A, French G. Glycopeptide tolerance in Staphylococcus aureus. J Antimicrobi Chemother. 1998; 42: 189-197. PMID: 9738836
7. Safdar A, Rolston KVI. Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer. Cancer. 2006; 106: 1815-1820. PMID: 16534785
8. Traczewski MM, Katz BD, Steenbergen JN, Brown SD. Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007. Antimicrob Agents Chemother. 2009; 53: 1735-1738. doi: 10.1128/AAC.01022-08 PMID: 19223623
9. Bae I-G, Federspiel JJ, Miró JM, Woods CW, Park L, Rybak MJ, et al. Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance. J Infect Dis. 2009; 200: 1355-1366. doi: 10.1086/606027 PMID: 19811099
10. Reipert A, Ehlert K, Kast T, Bierbaum G. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin. Antimicrob Agents Chemother. 2003; 47: 568-576. PMID: 12543661
11. Sujatha S, Praharaj I. Glycopeptide resistance in gram-positive cocci: a review. Interdis cip Perspect Infect Dis. 2012: 2012781679.
12. Deresinski S. Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2009; 199: 605-609. doi: 10.1086/596630 PMID: 19199551
13. Tenover FC, Moellering RC. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis. 2007; 44: 1208-1215. PMID: 17407040
14. Norazah A, Law NL, Kamel AGM, Salbiah N. The presence of heterogeneous vancomycin-lntermediate Staphylococcus aureus (heteroVISA) in a major Malaysian hospital. Med J Malaysia. 2012; 67: 269-273. PMID: 23082415
15. Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother. 2001; 47: 399-403. PMID: 11266410
16. Charles PGP, Ward PB, Johnson PDR, Howden BP, Grayson ML. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis. 2004; 38: 448-451. PMID: 14727222
17. Fong RKC, Low J, Koh TH, Kurup A. Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore. Eur J Clin Microbiol Infect Dis. 2009; 28: 983-987. doi: 10.1007/s10096-009-0741-5 PMID: 19387707
18. Ward PB, Johnson PD, Grabsch EA, Mayall BC, Grayson ML. Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aus. 2001; 175: 480-483. PMID: 11758077
19. Fowler VG, Sakoulas G, McIntyre LM, Meka VG, Arbeit RD, Stryiewski ME, et al. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and lowlevel in vitro resistance to thrombin-induced platelet microbicidal protein. J Infect Dis. 2004; 190: 1140-1149. PMID: 15319865
20. Tsuji BT, Rybak MJ, Lau KL, Sakoulas G. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2007; 51: 1089-1091. PMID: 17158941
21. Bardiau M, Yamazaki K, Duprez J-N, Taminiau B, Mainil JG, Otei I, et al. Genotypic and phenotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolated from milk of bovine mastitis. Lett Appl Microbiol. 2013; 57: 181-186. doi: 10.1111/lam.12099 PMID: 23659178
22. Bibalan MH, Shakeri F, Javid N, Ghaemi A, Ghaemi EA. Accessory Gene Regulator Types of Staphylococcus aureus Isolated in Gorgan, North of Iran. J Clin Diagn Res. 2014; 8: DC07-09. doi: 10.7860/ JCDR/2014/9713.5088 PMID: 25584216
23. Sakoulas G, Eliopoulos GM, Moellering RC, Wennersten C, Venkataraman L, Novick RP, et al. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother. 2002; 46: 1492-1502. PMID: 11959587
24. Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering RC. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis. 2004; 38: 1700-1705. PMID: 15227615
25. Hill-Cawthorne GA, Hudson LO, El Ghany MFA, Piepenburg O, Nair M, Dodqson A, et al. Recombinations in staphylococcal cassette chromosome mec elements compromise the molecular detection of methicillin resistance in Staphylococcus aureus. PloS One. 2014; 9: e101419. doi: 10.1371/journal. pone.0101419 PMID: 24972080
26. Stojanov M, Blanc DS. Characterization of the staphylococcal cassette chromosome mec insertion site in 108 isolates lacking the mecA gene and identified as methicillin-resistant Staphylococcus aureus by the Xpert MRSA assay. Eur J Clin Microbiol Infect Dis. 2014; 33: 1967-1971. doi: 10.1007/s10096-014-2169-9 PMID: 24906440
27. Borbón-Esquer EM, Villaseñor-Sierra A, Martínez-López E, Jáuregui-Lomeli JJ, Villaseñor-Martínez R, Ruiz-Briseño Mdel R. SCCmec types and pvl gene in methicillin-resistant Staphylococcus aureus strains from children hospitalized in a tertiary care hospital in Mexico. Scand J Infect Dis. 2014; 46: 523-527. doi: 10.3109/00365548.2014.912349 PMID: 24832853
28. Zhang K, McClure J-A, Elsayed S, Conly JM. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009; 53: 531-540. doi: 10.1128/AAC.01118-08 PMID: 19064897
29. Sakoulas G, Eliopoulos GM, Fowler VG, Moellering RC, Novick RP, Lucindo N, et al. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob Agents Chemother. 2005; 49: 2687-2692. PMID: 15980337
30. Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, et al. Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus. J Clin Microbiol. 2003; 41: 5-14. PMID: 12517819
31. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. M100-S23, January 2013.
32. Sakoulas G, Eliopoulos GM, Moellering RC, Novick RP, Venkataraman L, Wennersten C, et al. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?. J Infect Dis. 2003; 187: 929-938. PMID: 12660939
33. Zhang K, McClure J-A, Elsayed S, Louie T, Conly JM. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2005; 43: 5026-5033. PMID: 16207957
34. Gilot P, Lina G, Cochard T, Poutrel B. Analysis of the genetic variability of genes encoding the RNA IIIactivating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from cows with mastitis. J Clin Microbiol. 2002; 40: 4060-4067. PMID: 12409375
35. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover SC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003; 41: 5113-5120. PMID: 14605147
36. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC, Eliopoulos GM, et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004; 42: 2398-2402. PMID: 15184410
37. Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008; 46: 193-200. doi: 10.1086/524667 PMID: 18171250
38. Sakoulas G, Gold HS, Cohen RA, Venkataraman L, Moellering RC, Eliopoulos GM. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. J Antimicrob Chemother. 2006; 57: 699-704. PMID: 16464892
39. Sader HS, Jones RN, Rossi KL, Rybak MJ. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. J Antimicrob Chemother. 2009; 64: 1024-1028. doi: 10.1093/jac/dkp319 PMID: 19744978
40. Holmes RL, Jorgensen JH. Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006. Antimicrob Agents Chemother. 2008; 52: 757-760. PMID: 18039923
41. Jones RN. Key considerations in the treatment of complicated staphylococcal infections. Clin Microbiol Infect. 2008; 14 Suppl 2: 3-9. doi: 10.1111/j.1469-0691.2008.01923.x PMID: 18226084
42. Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Antimicrobial susceptibility of gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Internat J Antimicrob Agents. 2007; 30: 143-149. PMID: 17531446
43. Pitz AM, Yu F, Hermsen ED, Rupp ME, Fey PD, Olsen KM. Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates. J Clin Microbiol. 2011; 49: 269-274. doi: 10.1128/JCM.00914-10 PMID: 20962147
44. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002; 70: 631-641. PMID: 11796592
45. Vindel A, Cuevas O, Cercenado E, Marcos C, Bautista V, Castellares C, et al. Methicillin-Resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods. J Clin Microbiol. 2009; 47: 1620-1627. doi: 10.1128/JCM.01579-08 PMID: 19339473
46. Rose WE, Rybak MJ, Tsuji BT, Kaatz GW, Sakoulas G. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function. J Antimicrob Chemother. 2007; 59: 1190-1193. PMID: 17434881
47. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010; 23: 99-139. doi: 10.1128/CMR.00042-09 PMID: 20065327
48. Hanaki H, Labischinski H, Inaba Y, Kondo N, Murakami H, Hiramatsu K. Increase in glutamine-nonamidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. J Antimicrob Chemother. 1998; 42: 315-320. PMID: 9786471
49. Fukutsuji K, Yamada S, Harada T. Ultrastructural cell wall characteristics of clinical gentamycin-resistant Staphylococcus aureus isolates. Med Mol Morphol. 2013; 46: 70-76. doi: 10.1007/s00795-013-0009-0 PMID: 23338781
50. Hyo Y, Yamada S, Fukutsuji K, Harada T. Thickening of the cell wall in macrolide-resistant Staphylococcus aureus. Med Mol Morphol. 2013; 46: 217-224. doi: 10.1007/s00795-013-0027-y PMID: 23408211